Day: September 21, 2022

Springs Rejuvenation, Inc. Announces Exciting New Direction

Written by Customer Service on September 21, 2022. Posted in Public Companies.

ATLANTA, GA, Sept. 21, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Springs Rejuvenation, Inc., formerly Avra, Inc. (OTC Pink: SPRJ), announces an exciting new direction. Springs Rejuvenation, Inc., formerly, AVRA, Inc., (the public company) announced today that Management and Dr. Charles A. Pereyra, the founder of Springs Rejuvenation Stem Cell Therapy, LLC (the private company), who entered into a merger agreement in November 2021, have agreed that the companies will split and revert back to their pre-merger status. In the agreement that governs this action, Dr. Pereyra, through the private company, will retain the intellectual property of Springs Rejuvenation, including the name and web site and other related IP. The public company will retain the clinics that it has developed in Atlanta, GA and Ft. Lauderdale, FL, including all...

Genasys Inc. Receives New Emergency Management Software Services Contract from the West All Hazards Region of Colorado

Written by Customer Service on September 21, 2022. Posted in Public Companies.

SAN DIEGO, Sept. 21, 2022 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the global leader in critical communications systems and solutions that help keep people safe, today announced a multi-year Genasys Emergency Management (GEM) software-as-a-service (SaaS) contract from Colorado’s West All Hazards Region (West Region), which includes Delta, Gunnison, Hinsdale, Montrose, Ouray, and San Miguel counties. GEM is replacing a competitor’s software service. “Genasys’ comprehensive emergency management solution and Colorado’s year-round fire season were catalysts in facilitating our first GEM agreement in the state,” said Richard Danforth, Chief Executive Officer, Genasys Inc. “Home to some of Colorado’s most visited National Forests and tourist destinations, West Region public safety...

Veru to Participate in the Cantor Oncology, Hematology & HemeOnc Conference on September 28th, 2022

Written by Customer Service on September 21, 2022. Posted in Public Companies.

MIAMI, Sept. 21, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced that the Company will participate in the Cantor Oncology, Hematology, HemeOnc Conference to be held at the Lotte New York Palace in New York City on Wednesday, September 28, 2022. About Veru Inc.Veru is a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers. Infectious disease program: The Company has completed a positive Phase 3 COVID-19 study evaluating sabizabulin in hospitalized moderate to severe COVID-19 patients at high risk for ARDS. A double-blind,...

Group Black and Magnite Bring Programmatic Technology and Demand to Black-owned Publishers

Written by Customer Service on September 21, 2022. Posted in Public Companies.

NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Group Black, one of the largest collectives of Black-owned media and diverse creators, and Magnite, (NASDAQ: MGNI), the world’s largest independent sell-side advertising platform, today announced their collaboration to help Black-owned media scale their programmatic offerings. The joint effort aims to produce an increased revenue engine for these Black-owned brands while also strengthening the value proposition for companies who choose to work within Group Black’s collective. One of Group Black’s goals is to create a more equitable media landscape and to open up opportunities for Black-owned brands to scale at a rate larger than ever before. Combined with Magnite’s advertising technology that functions across every channel and format—including desktop, mobile, audio and video— Black-owned...

IDT Corporation to Report Fourth Quarter and Fiscal Year 2022 Results

Written by Customer Service on September 21, 2022. Posted in Public Companies.

NEWARK, NJ , Sept. 21, 2022 (GLOBE NEWSWIRE) — IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications services, has scheduled its report of financial and operational results for the fourth quarter and fiscal year 2022 fiscal year (the three and twelve months ended July 31st) on Thursday, October 6, 2022. IDT’s earnings release will be issued and posted on the IDT investor relations website (https://www.idt.net/investors-and–media) at approximately 4:30 PM Eastern. IDT will host an earnings conference call beginning at 5:30 PM Eastern with management’s discussion of results, outlook, and strategy followed by Q&A with investors. To listen to the call and participate in the Q&A, dial 1-888-506-0062 (toll-free from the US) or 1-973-528-0011 (international)...

iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline

Written by Customer Service on September 21, 2022. Posted in Mergers And Acquisitions.

– Positions Company for leadership in AI-powered drug discovery – – Expands iBio’s immuno-oncology pipeline with three new candidates – – Hosting investor call on September 27th to discuss transaction, the Company’s transformation and FY2022 financial results – SAN DIEGO and BRYAN, Texas, Sept. 21, 2022 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming® Manufacturing System, today announced that it closed on the acquisition of substantially all of the assets of its partner, RubrYc Therapeutics, Inc. (“RubrYc”) after it entered into a definitive asset purchase agreement (the “Purchase Agreement”). The transaction marks another important step toward iBio’s mission to bring more – and better – immunotherapies to the clinic,...

WSP Completes Acquisition of the Environment & Infrastructure Business of John Wood Group plc, Expanding Its Environmental Leadership

Written by Customer Service on September 21, 2022. Posted in Mergers And Acquisitions.

MONTREAL, Sept. 21, 2022 (GLOBE NEWSWIRE) — WSP Global Inc. (TSX: WSP) (“WSP” or the “Corporation”) is pleased to announce that it has completed its previously announced acquisition of the Environment & Infrastructure business (“E&I”) of John Wood Group plc (“Wood”), through a sale and purchase agreement (the “Acquisition”). E&I provides engineering, remediation consulting, environmental permitting, inspection, monitoring, and environmental management services to government, industrial, infrastructure, oil and gas, power, water, and mining clients. E&I’s 6,000 professionals are based in some 100 offices in over ten countries, mainly in the US, Canada, and the UK, with a secondary presence in Latin America and Europe. “We are pleased to welcome E&I’s...

Landec Corporation Sets First Quarter 2023 Earnings Conference Call for October 5, 2022 at 2:00 p.m. PT

Written by Customer Service on September 21, 2022. Posted in Public Companies.

SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 21, 2022 (GLOBE NEWSWIRE) — Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – today announced that it will host a conference call to discuss fiscal 2023 first quarter financial results. The live webcast can be accessed via Landec’s website on the Investor Events & Presentations page. The webcast will be available for 30 days. Date: Wednesday, October 5, 2022 Time: 2:00 p.m. Pacific time (5:00 p.m. Eastern time) Direct Webcast...

Immunovant to Present at Roivant Investor Day on September 28th

Written by Customer Service on September 21, 2022. Posted in Public Companies.

NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for people with autoimmune diseases, today announced that Pete Salzmann, M.D., Chief Executive Officer, will present a corporate update at Roivant’s Investor Day, taking place on September 28th, 2022.Roivant Investor Day presentation details: Date: Wednesday, September 28th, 2022 Time: 11:15 am Eastern Time Webcast: The presentation will be available via webcast and can be accessed at the Investor Relations section of the Company’s website, located at www.immunovant.com.About Immunovant, Inc. Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As a leader in FcRn...

Blue Water Vaccines to Present at World Vaccine Congress Europe 2022

Written by Customer Service on September 21, 2022. Posted in Public Companies.

CINCINNATI, Sept. 21, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that the Company will host a roundtable discussion and present at the World Vaccine Congress Europe 2022 in Barcelona, Spain. On Wednesday, October 12, 2022, at 11am Central European Time, BWV will host a roundtable discussion entitled, “Mathematical Modeling for Identification of Antigens for Novel Vaccine Development,” moderated by Dr. Sunetra Gupta, Professor of Theoretical Epidemiology at The University of Oxford and member of the BWV Scientific Advisory Board. In addition to the roundtable, Dr. Gupta will deliver a presentation on the current status and progress of the Company’s...

Day: September 21, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals